AbioMed AbioCor Artificial Heart Cost Effectiveness Hinges On Longevity
This article was originally published in The Gray Sheet
Executive Summary
AbioMed eventually must show that the AbioCor implantable artificial heart can extend a patient's life at least three years to justify the nearly $300,000 average cost of each implant, according to company consultant Mehmet Oz, MD.
You may also be interested in...
Abiomed Passes Midway Point Of AbioCor Trial With Eighth Implant
Eight Abiomed AbioCor total artificial hearts have been implanted as of Jan. 7, marking the halfway-point of the company's clinical trial to support a PMA application in 2004
Abiomed Passes Midway Point Of AbioCor Trial With Eighth Implant
Eight Abiomed AbioCor total artificial hearts have been implanted as of Jan. 7, marking the halfway-point of the company's clinical trial to support a PMA application in 2004
Thoratec Makes Case For Permanent VAD Higher Medicare Reimbursement
Thoratec is expecting CMS to boost Medicare reimbursement for mechanical cardiac assist device implantation based on data showing that the firm's HeartMate XVE left ventricular assist device (LVAD) is a cost-effective destination therapy for end-stage heart failure patients